A look at the clinical progress of anti-Aβ monoclonal antibodies and how precision delivery is shaping the next generation of ...
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer.
The agency cleared lab-based and point-of-care infectious disease and clinical chemistry tests as well as software for digital pathology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback